PMA device
Artisan Myopia
Ophtec BV · Lens, Intraocular, Phakic (MTA, Class III) · First FDA decision Nov 15, 2024, newest Nov 15, 2024Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Artisan Myopia"
MAUDE reports
1
Brand "Artisan Myopia", since 2015
PubMed studies
7
Mentioning "Artisan Myopia"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Artisan Myopia
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Artisan MyopiaPMA supplement
P030028-S010 · Decided Nov 15, 2024 · 961 days after receipt · Normal 180 Day Track No User Fee
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Artisan Myopia", any status and sponsor, newest update first.
No registered device study names "Artisan Myopia".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Artisan Myopia", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code MTA
18,526 reports: 3,641 malfunction, 14,883 injury, 2 death
Newest reports for this brand
- ARTISAN MYOPIA 6/8.5Injury
8040449-2021-00003 · Received Jun 7, 2021 · Event dated Apr 14, 2021
Device type: Lens, Intraocular, Phakic (MTA)
Device problem as coded: Output Problem
Patient problem as coded: Corneal Decompensation
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Artisan Myopia"[tiab]. The summary above synthesizes these.
- Retropupillary Iris Fixation of an Artisan Myopia Lens for Intraocular Lens Dislocation and Aphakia in Eyes with Extremely High Myopia: A Case Series and a Literature Review.
Yoo TK, Lee SM, Lee H, et al. · Ophthalmol Ther · 2022
- Long-Term Endothelial Cell Loss in Patients with Artisan Myopia and Artisan Toric Phakic Intraocular Lenses: 5- and 10-Year Results.
Jonker SMR, Berendschot TTJM, Ronden AE, et al. · Ophthalmology · 2018Comparative Study
- Experience with the Artisan phakic intraocular lens in Asian eyes.
Asano-Kato N, Toda I, Hori-Komai Y, et al. · J Cataract Refract Surg · 2005
- U.S. clinical investigation of the Artisan myopia lens for the correction of high myopia in phakic eyes. Report of the results of phases 1 and 2, and interim phase 3.
Alexander L, John M, Cobb L, et al. · Optometry · 2000Clinical Trial, Clinical Trial, Phase I
- Iris-claw phakic intraocular lens for high myopia.
Landesz M, van Rij G, Luyten G · J Refract Surg · 2001
- A retrospective analysis of the first Indian experience on Artisan phakic intraocular lens.
Senthil S, Reddy KP · Indian J Ophthalmol · 2006
- A retrospective analysis of the first Yemeni experience on Artisan phakic intraocular lens for the treatment of moderate and high myopia.
Bamashmus MA, Mohamed AA, Alakhlee HA · Oman J Ophthalmol · 2012
Other devices of this type
Also filed under product code MTA.
- Visian Icl (Implantable Collamer Lens)STAAR Surgical Company · PMA 2025
- EVO Visian Implantable Collamer Lens for Myopia (VICMO)STAAR Surgical Company · PMA 2025
- EVO/EVO+ VISIAN® Implantable Collamer® LensesSTAAR Surgical Company · PMA 2022
- Visian Toric ICL (Implantable Collamer Lens)STAAR Surgical Company · PMA 2019
- ARTISAN/Verisyse Myopia Phakic Intraocular Lens (IOL)Ophtec BV · PMA 2018
- Staar Surgical Implantable Collamer Lens (Vision Icl)STAAR Surgical Company · PMA 2017
- EVO/EVO+VISIAN Implantable Collamer LensSTAAR Surgical Company · PMA 2022
- Visian Implantable Collamer LensesSTAAR Surgical Company · PMA 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.